MAM
GDC Technology taps Joshua Chan as director, sales & marketing
MUMBAI: Singapore-headquartered GDC Technology, provider of digital cinema solutions, has announced its plans to expand its business operation with the appointment of Joshua Chan as director of sales and marketing.
Besides leading the sales and marketing efforts at GDC Technology, Joshua Chan will also look after the company’s digital and electronic cinema businesses.
Prior to joining GDC Technology, Joshua was Kodak’s country business unit manager for Singapore, Indonesia and Malaysia. He had earlier handled Singapore and other export markets including South Asia as well as Indo-China where he grew the businesses and market shares, working with the various distributors in the respective countries. Joshua spent 13 years at Kodak in Singapore primarily with Entertainment Imaging, the division that supplies products and services to the motion picture and television industry, informs an official release.
Joshua is quoted in the release as saying, “Having been in the motion picture industry all this while, I have been excited about the evolution of digital cinema. I am looking forward to joining GDC Technology, one of the pioneers and leaders in the field. I am committed to ensuring that we achieve our revenue targets. We are now experiencing a structural shift in the traditional film business and I am determined to win in these new digital markets with the elite engineering team at GDC Technology.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
